Journal Article (Review Article) DKFZ-2021-00395

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review.

 ;  ;  ;  ;  ;  ;  ;

2021
Springer Heidelberg

EJNMMI Research 11(1), 18 () [10.1186/s13550-021-00761-2]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018. While most of the existing literature has been focussed on the application of FAP-specific PET in various kinds of cancers, some researchers have, both intentionally or unintentionally, used FAP-specific PET in patients with non-cancerous diseases. The purpose of this systematic review is therefore to summarize the available evidence of FAP-specific PET for non-malignant indications.The MEDLINE database was searched for studies presenting the clinical use of FAP-specific PET, the records were screened according to PRISMA guidelines and articles containing patients suffering from non-malignant diseases were included.Sixteen studies with 303 patients were included. FAP-specific PET has been used in cardiac imaging, IgG4-related disease, benign tumors as well as various kinds of inflammation. Two prospective studies on FAP-specific PET for IgG4-related disease show its potential to differentiate inflammatory from fibrotic lesions, which could be used to determine the management of these patients.While publications on FAP-specific PET for non-malignant indications are mostly limited to case reports and incidental findings, the first retrospective and prospective studies present promising results for IgG4-related as well as cardiovascular disease that warrant further research. Several currently recruiting trials will add to the body evidence in the next few years.

Keyword(s): FAP ; Fibroblast activation protein ; Fibroblasts ; PET ; PET-CT ; Positron emission tomography

Classification:

Note: #LA:E050#

Contributing Institute(s):
  1. E050 KKE Strahlentherapie (E050)
  2. DKTK HD zentral (HD01)
  3. E060 KKE Nuklearmedizin (E060)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2021
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2021-02-22, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)